Never miss a story — sign up for PEOPLE’s free daily newsletter to stay up-to-date on the best of what PEOPLE has to offer, from juicy celebrity news to compelling human interest stories
“At that time, all retailers and consumers were instructed to return or destroy the product,” said the spokesperson in a statement. “We take this issue seriously and continue to work closely with the FDA to evaluate any potential safety risks associated with Zantac.”
The representative added: “At Sanofi, we stand by the long-standing science that supports the safety of Zantac OTC products, which have been used by consumers for over two decades.”
FDA officials will send notices to ranitidine manufacturers and ask that they withdraw the products from the market. The administration said consumers who currently have the products should properly dispose of them, and those prescribed ranitidine should contact their doctor.
Other similar products that FDA testing hasn’t found NDMA in, to date, include Pepcid, Tagamet, Nexium, Prevacid and Prilosec, according to a press release.
“The FDA is committed to ensuring that the medicines Americans take are safe and effective,” said Woodcock. “We make every effort to investigate potential health risks and provide our recommendations to the public based on the best available science.”
Source: Read Full Article